Show simple item record

dc.contributor.authorPan American Health Organization
dc.description.abstractIn January 2020, the etiologic agent responsible for a cluster of severe pneumonia cases in Wuhan, China, was identified as being a novel betacoronavirus, distinct from SARS-CoV and MERS-CoV. On 11 February 2020, the International Committee on Taxonomy of Viruses (ICTV) announced that the virus was named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). On the same day, WHO named the disease as coronavirus disease COVID-19. For communication purposes, we will refer the virus as “the virus responsible for COVID-19†or “the COVID-19 virus†. Complete genomic sequences of the COVID-19 virus have been released and different molecular detection protocols developed but not fully validated yet. However, given the current circulation of COVID-19 in the Americas region, the Pan American Health Organization/World Health Organization (PAHO/WHO) recommends to Member States to ensure timely identification of suspect cases, collection and shipment of samples to reference laboratories, and implementation of molecular detection protocols, according to the laboratory capacity.
dc.subjectInfecctious Diseases
dc.titleLaboratory Guidelines for the Detection and Diagnosis of COVID-19 Virus Infection, 8 July 2020
eihealth.countryRegional, Americas (PAHO/OPS)
eihealth.categoryInfection prevention and control, including health care workers protection
eihealth.typeWHO/PAHO Guidance
eihealth.maincategorySlow Spread / Reducir la Dispersión

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record